Efficacy and Toxicity of Total Neoadjuvant Sandwich Treatment Via Short Course Radiotherapy in the Treatment of Stage II and III Rectal Cancer Patients

Efficacy and Toxicity of Total Neoadjuvant Sandwich Treatment Via Short Course Radiotherapy in the Treatment of Stage II and III Rectal Cancer Patients is a phase 2, interventional study registered as NCT07095439 by Ain Shams University, with a registry enrolment figure of 38 participants, started 2023-09-01 and due to reach its primary completion in 2026-01-01. Interventions recorded: Total Neoadjuvant Treatment. Conditions listed: Rectal Cancer. Primary outcome: Pathological complete response. Colorectal eligibility wording from the registry: "* Pathologically confirmed rectal adenocarcinoma of low or mid rectum (less than 16 cm from the anal verge on endoscopy)". Sites: Egypt. No results are recorded here; the registry entry is the source.